- October 19, 2017
Second annual Harvard FUSION symposium explores the Science and Business of Combating Antibiotic Resistance
- August 24, 2016
Harvard scientists identify spark plug that ignites nerve cell damage in Lou Gehrig’s disease
- March 21, 2016
Research alliance will advance small-molecule therapy for most common form of acute leukemia, targeting proteins involved in transcriptional regulation.
- December 23, 2015
UCB-funded Harvard study describes the pre-clinical development of a therapeutic that could potentially be used to treat type 2 diabetes, fatty liver disease, and other metabolic diseases.
- September 28, 2015
A molecule isolated from sea sponges and synthesized at Harvard can halt the growth of cancerous cells.
Page 1 of 2